Intuitive Surgical (ISRG) Stock Forecast & Price Target

Compare

8,875 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ISRG Analyst Ratings

Strong Buy

12 Buy

4 Hold

0 Sell

Based on 16 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ISRG Stock 12 Month Forecast

Average Price Target

$650.38

▲(24.12% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $650.38 with a high forecast of $750.00 and a low forecast of $550.00. The average price target represents a 24.12% change from the last price of $523.99.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"437":"$437","594":"$594","751":"$751","515.5":"$515.5","672.5":"$672.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":750,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$750.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":650.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$650.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":550,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$550.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[437,515.5,594,672.5,751],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,566.36,580.4861538461539,594.6123076923077,608.7384615384616,622.8646153846154,636.9907692307693,651.1169230769231,665.243076923077,679.3692307692307,693.4953846153846,707.6215384615384,721.7476923076923,735.8738461538462,{"y":750,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,566.36,572.8230769230769,579.2861538461539,585.7492307692307,592.2123076923077,598.6753846153846,605.1384615384616,611.6015384615384,618.0646153846154,624.5276923076923,630.9907692307693,637.4538461538461,643.916923076923,{"y":650.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,566.36,565.1015384615384,563.843076923077,562.5846153846154,561.3261538461538,560.0676923076924,558.8092307692308,557.5507692307692,556.2923076923076,555.0338461538462,553.7753846153846,552.516923076923,551.2584615384616,{"y":550,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":521.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":553.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":483.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":469.07,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":438.04,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":534.28,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.37,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":566.36,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$750.00

Average Price Target$650.38

Lowest Price Target$550.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Newitter

Truist Financial

$650

Buy

24.05%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Truist Financial

Adam Maeder

Piper Sandler

$610→$620

Buy

18.32%

Upside

Reiterated

01/23/26

Piper Sandler Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Suraj Kalia

Oppenheimer

Hold

―

Reiterated

01/23/26

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)

Anthony Petrone

Mizuho Securities

Hold

―

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Intuitive Surgical (NASDAQ: ISRG) and Sanofi (Other OTC: SNYNF)

Joanne Wuensch

Citi

$635→$590

Hold

12.60%

Upside

Reiterated

01/23/26

Intuitive Surgical price target lowered to $590 from $635 at CitiIntuitive Surgical price target lowered to $590 from $635 at Citi

Larry Biegelsen

Wells Fargo

$600→$654

Buy

24.81%

Upside

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), OnKure Therapeutics (NASDAQ: OKUR) and Praxis Precision Medicines (NASDAQ: PRAX)

Lee Hambright

Bernstein

$740→$750

Buy

43.13%

Upside

Reiterated

01/23/26

Intuitive Surgical price target raised to $750 from $740 at BernsteinIntuitive Surgical price target raised to $750 from $740 at Bernstein

Vijay Kumar

Evercore ISI

$580→$550

Hold

4.96%

Upside

Reiterated

01/23/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (NASDAQ: CORT), Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Brandon Vazquez

William Blair

Buy

―

Reiterated

01/23/26

Intuitive Surgical: Durable Growth, Operating Leverage, and Premium-Valuation Upside Through 2026

Rick Wise

Stifel Nicolaus

$670

Buy

27.87%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Stifel Nicolaus

Ryan Zimmerman

BTIG

$616

Buy

17.56%

Upside

Reiterated

01/23/26

Intuitive Surgical: Durable Growth, Expanding Moat, and Attractive Upside Support Buy Rating and $616 Target

Shagun Singh Chadha

RBC Capital

$650

Buy

24.05%

Upside

Reiterated

01/20/26

Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Karyopharm Therapeutics (KPTI)

Travis Steed

Bank of America Securities

$650

Buy

24.05%

Upside

Reiterated

01/19/26

Intuitive Surgical (ISRG) Receives a Buy from Bank of America Securities

David Roman

Goldman Sachs

$621→$714

Buy

36.26%

Upside

Reiterated

01/09/26

Intuitive Surgical price target raised to $714 from $621 at Goldman SachsIntuitive Surgical price target raised to $714 from $621 at Goldman Sachs

Matt Miksic

Barclays

$635→$686

Buy

30.92%

Upside

Reiterated

01/07/26

Barclays Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Newitter

Truist Financial

$650

Buy

24.05%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Truist Financial

Adam Maeder

Piper Sandler

$610→$620

Buy

18.32%

Upside

Reiterated

01/23/26

Piper Sandler Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Suraj Kalia

Oppenheimer

Hold

―

Reiterated

01/23/26

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (NASDAQ: ISRG) and Abbott Laboratories (NYSE: ABT)

Anthony Petrone

Mizuho Securities

Hold

―

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Intuitive Surgical (NASDAQ: ISRG) and Sanofi (Other OTC: SNYNF)

Joanne Wuensch

Citi

$635→$590

Hold

12.60%

Upside

Reiterated

01/23/26

Intuitive Surgical price target lowered to $590 from $635 at CitiIntuitive Surgical price target lowered to $590 from $635 at Citi

Larry Biegelsen

Wells Fargo

$600→$654

Buy

24.81%

Upside

Reiterated

01/23/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), OnKure Therapeutics (NASDAQ: OKUR) and Praxis Precision Medicines (NASDAQ: PRAX)

Lee Hambright

Bernstein

$740→$750

Buy

43.13%

Upside

Reiterated

01/23/26

Intuitive Surgical price target raised to $750 from $740 at BernsteinIntuitive Surgical price target raised to $750 from $740 at Bernstein

Vijay Kumar

Evercore ISI

$580→$550

Hold

4.96%

Upside

Reiterated

01/23/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (NASDAQ: CORT), Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Brandon Vazquez

William Blair

Buy

―

Reiterated

01/23/26

Intuitive Surgical: Durable Growth, Operating Leverage, and Premium-Valuation Upside Through 2026

Rick Wise

Stifel Nicolaus

$670

Buy

27.87%

Upside

Reiterated

01/23/26

Intuitive Surgical (ISRG) Gets a Buy from Stifel Nicolaus

Ryan Zimmerman

BTIG

$616

Buy

17.56%

Upside

Reiterated

01/23/26

Intuitive Surgical: Durable Growth, Expanding Moat, and Attractive Upside Support Buy Rating and $616 Target

Shagun Singh Chadha

RBC Capital

$650

Buy

24.05%

Upside

Reiterated

01/20/26

Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Karyopharm Therapeutics (KPTI)

Travis Steed

Bank of America Securities

$650

Buy

24.05%

Upside

Reiterated

01/19/26

Intuitive Surgical (ISRG) Receives a Buy from Bank of America Securities

David Roman

Goldman Sachs

$621→$714

Buy

36.26%

Upside

Reiterated

01/09/26

Intuitive Surgical price target raised to $714 from $621 at Goldman SachsIntuitive Surgical price target raised to $714 from $621 at Goldman Sachs

Matt Miksic

Barclays

$635→$686

Buy

30.92%

Upside

Reiterated

01/07/26

Barclays Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

xxx

Success Rate

23/29 ratings generated profit

Average Return

+8.36%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 79.31% of your transactions generating a profit, with an average return of +8.36% per trade.

1 Year

Lee HambrightBernstein

Success Rate

17/18 ratings generated profit

Average Return

+24.17%

reiterated a buy rating 3 days ago

Copying Lee Hambright's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +24.17% per trade.

2 Years

xxx

Success Rate

32/33 ratings generated profit

Average Return

+59.94%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 96.97% of your transactions generating a profit, with an average return of +59.94% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISRG Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ISRG has received 31 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. ISRG average Analyst price target in the past 3 months is 650.38.

Each month's total comprises the sum of three months' worth of ratings.

ISRG Financial Forecast

ISRG Earnings Forecast

Next quarter’s earnings estimate for ISRG is $2.13 with a range of $2.03 to $2.53. The previous quarter’s EPS was $2.53. ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.

ISRG Sales Forecast

Next quarter’s sales forecast for ISRG is $2.62B with a range of $2.56B to $2.73B. The previous quarter’s sales results were $2.87B. ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year ISRG has Performed in-line its overall industry.

ISRG Stock Forecast FAQ

What is ISRG’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 650.38.

What is ISRG’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 24.12% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ISRG a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Strong Buy which is based on 12 buy ratings, 4 hold ratings and 0 sell ratings.

What is Intuitive Surgical’s price target?

The average price target for Intuitive Surgical is 650.38. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $750.00 ,the lowest forecast is $550.00. The average price target represents 24.12% Increase from the current price of $523.99.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of ISRG?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (ISRG) Stock Forecast & Price Target

ISRG Analyst Ratings

ISRG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

ISRG Analyst Recommendation Trends

ISRG Financial Forecast

ISRG Earnings Forecast

ISRG Sales Forecast

ISRG Stock Forecast FAQ

Detailed List of Analyst Forecasts